555 related articles for article (PubMed ID: 6801128)
1. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
Pearlstein E; Sorvillo J; Gigli I
J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
[TBL] [Abstract][Full Text] [Related]
2. Requirements for the binding of human plasma fibronectin to the C1q subunit of the first component of complement.
Sorvillo J; Gigli I; Pearlstein E
J Immunol; 1983 Sep; 131(3):1400-4. PubMed ID: 6309962
[TBL] [Abstract][Full Text] [Related]
3. Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.
Carsons SE; Schwartzman S; Diamond HS; Berkowitz E
Clin Exp Immunol; 1988 Apr; 72(1):37-42. PubMed ID: 3135129
[TBL] [Abstract][Full Text] [Related]
4. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
[TBL] [Abstract][Full Text] [Related]
5. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin binds to C1q: possible mechanisms for their co-precipitation in cryoglobulins from patients with systemic lupus erythematosus.
Kono I; Sakurai T; Kabashima T; Yamane K; Kashiwagi H
Clin Exp Immunol; 1983 May; 52(2):305-10. PubMed ID: 6602675
[TBL] [Abstract][Full Text] [Related]
7. Characterization of C1q by monoclonal antibodies.
Heinz HP; Loos M
Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
[TBL] [Abstract][Full Text] [Related]
8. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
Heinz HP; Burger R; Golan MD; Loos M
J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
[TBL] [Abstract][Full Text] [Related]
9. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
10. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
[TBL] [Abstract][Full Text] [Related]
11. C1q binding and C1 activation by various isolated cellular membranes.
Storrs SB; Kolb WP; Olson MS
J Immunol; 1983 Jul; 131(1):416-22. PubMed ID: 6602834
[TBL] [Abstract][Full Text] [Related]
12. In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.
Veerhuis R; van Es LA; Daha MR
Immunology; 1985 Apr; 54(4):801-10. PubMed ID: 3872261
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
[TBL] [Abstract][Full Text] [Related]
14. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal anti-mouse macrophage antibodies recognize the globular portions of C1q, a subcomponent of the first component of complement.
Heinz HP; Dlugonska H; Rüde E; Loos M
J Immunol; 1984 Jul; 133(1):400-4. PubMed ID: 6609989
[TBL] [Abstract][Full Text] [Related]
16. Fibronectin binding to C1q associated with antigen-antibody complexes in EDTA-treated plasma.
Sorvillo J; Gigli I; Pearlstein E
Scand J Immunol; 1986 Feb; 23(2):153-60. PubMed ID: 3081998
[TBL] [Abstract][Full Text] [Related]
17. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
[TBL] [Abstract][Full Text] [Related]
18. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1.
Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R
J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976
[TBL] [Abstract][Full Text] [Related]
19. The effect of fibronectin on the processing of C1q- and C3b/bi-coated immune complexes by peripheral blood monocytes.
Sorvillo JM; Gigli I; Pearlstein E
J Immunol; 1986 Feb; 136(3):1023-6. PubMed ID: 3484498
[TBL] [Abstract][Full Text] [Related]
20. The C1q subunit of the first component of complement binds to laminin: a mechanism for the deposition and retention of immune complexes in basement membrane.
Bohnsack JF; Tenner AJ; Laurie GW; Kleinman HK; Martin GR; Brown EJ
Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3824-8. PubMed ID: 2987948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]